Search

Search Results
Results 1601 - 1610 of 6671 for Cancer pain
  • Drug - 30 Jul 2024
    Consumer Medicine Information (CMI) about ZolaCos CP intended for persons living in Australia.
  • News - 9 Jul 2024
    New research led by UCLA Health has found a drug that treats insomnia works to prevent the addictive effects of the morphine opioids in mice while still providing effective pain relief.
  • Drug - 28 Jun 2024
    Consumer Medicine Information (CMI) about Tibsovo intended for persons living in Australia.
  • Drug - 26 Jun 2024
    Consumer Medicine Information (CMI) about Zejula Tablets intended for persons living in Australia.
  • Drug - 29 May 2024
    Consumer Medicine Information (CMI) about Oncaspar LYO intended for persons living in Australia.
  • Drug - 16 May 2024
    Consumer Medicine Information (CMI) about DBL Gemcitabine Injection intended for persons living in Australia.
  • News - 2 May 2024
    Globally, there are substantial differences between females and males (aged 10 and older) when it comes to health, with limited progress in bridging these health gaps over the past 30 years, according...
  • News - 26 Mar 2024
    One January morning in 2021, Carol Rosen took a standard treatment for metastatic breast cancer. Three gruesome weeks later, she died in excruciating pain from the very drug meant to prolong her life.
  • News - 15 Feb 2024
    Chula researchers have developed a remarkable wireless hepatitis B virus test kit to screen for infection and collect data for an online database that's fast and complete in one step. Industrial...
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Zejula intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.